Nu Skin Unveils Prysm iO™: An Evolution in Intelligent Nutritional Wellness

Key Terms

carotenoids medical

Carotenoids are natural pigments produced by plants, algae and some microbes that give foods like carrots and tomatoes their red, orange or yellow color and can act as antioxidants in the body. Investors care because these compounds are used in dietary supplements, food coloring, cosmetics and some medical products, so changes in scientific evidence, regulation, supply or production costs can affect sales, margins and valuations for companies that make or sell them.

oxidative stress medical

Oxidative stress is a biological imbalance where damaging, unstable molecules overwhelm the body’s neutralizing defenses, similar to how rust forms when metal is exposed to oxygen and moisture. Investors should care because oxidative stress is linked to many diseases and aging processes, influencing demand for drugs, diagnostics, supplements, and healthcare spending, and it can affect the commercial value and regulatory outlook of related products.

hyperspectral technical

Hyperspectral describes imaging or sensing that captures light across hundreds of very narrow color bands, producing detailed “spectral fingerprints” that reveal material composition or subtle conditions ordinary cameras miss—like seeing many more colors than the human eye to tell apart similar objects. For investors, hyperspectral technology can signal companies with advanced analytics or unique data products used in agriculture, mining, defense, environmental monitoring and manufacturing, potentially enabling higher-value services, new revenue streams and competitive differentiation.

raman-spectroscopy medical

A laboratory technique that uses a beam of light to probe how molecules in a sample change that light, producing a signature pattern that identifies the sample’s chemical makeup and structure. Investors care because it provides fast, non‑destructive quality control, materials testing and diagnostic data—think of it as a molecular fingerprint or musical note that helps companies verify product purity, speed research and spot manufacturing problems without destroying the item.

randomized, double-blind, placebo-controlled medical

A "randomized, double-blind, placebo-controlled" process is a method used to test the effectiveness of a new treatment or intervention. Participants are randomly assigned to different groups, with one receiving the real treatment and the other a fake version, called a placebo. Neither the participants nor the researchers know who is receiving which, which helps ensure unbiased results. For investors, this rigorous approach increases confidence that the findings are accurate and not influenced by guesswork or bias.

serum medical

The clear, yellowish fluid obtained from blood after clotting has been removed; it contains proteins, antibodies and other molecules used to measure health markers. Investors pay attention because serum is the sample used in many medical tests, drug development studies and regulatory safety checks—results from those tests can change a therapy’s market prospects much like a quality report can sway a product’s sales outlook.

cagr financial

Compound Annual Growth Rate (CAGR) measures the average yearly growth of an investment, revenue, or other metric over a multi-year period as if it had grown at a steady rate each year. Think of it like the constant speed that would take you from the starting value to the ending value over the same time—useful because it smooths out ups and downs and lets investors compare different assets or performance periods on an even footing.

ai-powered technical

"AI-powered" describes technology that uses artificial intelligence to perform tasks, make decisions, or analyze information automatically. It’s similar to having a highly skilled assistant that can learn from data, recognize patterns, and improve over time, helping to make processes faster and more accurate. For investors, this means better insights and more efficient operations, potentially leading to smarter investment choices.

New AI-powered platform provides real-time insights into antioxidant health, transforming how people understand and manage their nutritional wellness

PROVO, Utah--(BUSINESS WIRE)-- Nu Skin Enterprises Inc. (NYSE: NUS), the world’s #1 company for beauty and wellness device systems*, introduced Prysm iO™, a breakthrough intelligent nutritional wellness platform designed to provide powerful insights into one’s personal health and wellness by helping users track their carotenoid levels, key nutrients that combat oxidative stress in the body. This proprietary intelligent wellness device and associated app is being released exclusively to Nu Skin brand representatives beginning in the fourth quarter and will be made available to the broader public market throughout 2026.

The Prysm iO intelligent nutritional wellness platform is designed to provide powerful insights into one’s personal health and wellness by helping users track their carotenoid levels, key nutrients that combat oxidative stress in the body. A simple and non-invasive finger-scan on the compact, portable device gives you real data in less than 15 seconds without lab visits or complicated testing.

Prysm iO uses advanced skin-scanning technology to provide a fingertip measurement of carotenoids, powerful antioxidants that reflect the body’s nutritional status and overall antioxidant health. This AI-powered platform provides powerful insights across the four key domains of health, including diet, fitness, lifestyle and supplementation. A simple and non-invasive finger-scan on the compact, portable device gives you real data in less than 15 seconds without lab visits or complicated testing.

"Prysm iO isn’t just a device, it’s a shift toward intelligent, personalized wellness," said Ryan Napierski, president and CEO. "People are investing significant time, effort and money into their health but still asking, ‘Is what I'm doing actually working?’ Prysm iO gives them clear, real-time insights backed by science so they can make informed choices that support their goals. We’re giving people clearer insights into their health so they can make more informed choices and move forward with confidence."

Grounded in 20+ Years of Research

Built on over two decades of carotenoid science and measurement innovation, Prysm iO incorporates patent-pending Spectral Rai Technology, which captures more than 70,000 hyperspectral absorption measurements (6,000+ per second) per scan. A proprietary AI-powered algorithm then converts that data into a personalized “Prysm Score,” leveraging proven Raman-spectroscopy techniques to turn complex readings into simple insight. This intelligent platform is strengthened by a database of more than 21 million antioxidant scans of more than 10 million people in nearly 50 countries from Nu Skin’s BioPhotonic Scanners, providing a unique ability to aggregate insights and trends.

Actionable Insights That Empower

With each scan, users receive their personal Prysm Score plus tailored feedback on how their current nutrition and supplement routine supports antioxidant levels. When used regularly, Prysm iO enables tracking of progress over time, helping users make informed adjustments to their routines for better wellness outcomes.

Prysm iO integrates seamlessly with Nu Skin’s broader wellness ecosystem, including Prysm-certified supplements such as LifePak^®, MYND360™ Mind Full, Beauty Focus^® Collagen+, ageLOC^® Youth, Pharmanex^® Eye Formula and G3^®. These Prysm-certified supplements are clinically proven and guaranteed to improve an individual’s Prysm Score.

Clinically Tested for Precision and Impact

In a recent randomized, double-blind, placebo-controlled study of 46 healthy adults conducted by Nu Skin, both the BioPhotonic Scanner S3 and a Prysm iO prototype demonstrated similar carotenoid tracking capabilities. Participants taking targeted supplements experienced:

• 43 to 46% increases in skin carotenoid levels after 12 weeks as measured by the S3 and Prysm iO prototype
• 44% increase in serum vitamin C levels
• 26% increase in serum selenium levels

In addition, self-reported benefits included higher energy levels (71% of participants), improved overall health (75%) and stronger immune support (82%).

Additional studies with prestigious, worldwide universities are nearing completion with results expected early next year. This includes research with Dr. Anne Chang of Stanford Medicine, Dr. Cai of Jiao Tong University in China and Dr. Hanjoe Kim of Yonsei University in South Korea.

Launching into a Growing Personalized-Wellness Landscape

Prysm iO arrives at a pivotal moment when consumers demand personalized, data-driven wellness solutions. With Statista Research projecting the global wellness market to reach $9 trillion by 2028 and connected health technologies growing at more than 20% CAGR according to Grand View Research, Nu Skin is positioned to lead with innovation and insight.

Internal research indicates strong commercial momentum: 84% of Nu Skin brand affiliates believe Prysm iO will help attract new customers, and 62% of surveyed consumers expressed interest in purchasing supplements after learning about the technology.

Launch Timeline

Prysm iO is now available for qualified Nu Skin brand representatives. Consumers will be able to purchase devices from Nu Skin brand representatives in early 2026 with a full consumer launch scheduled for mid-2026. This phased rollout ensures product availability, training and platform support across markets.

About Nu Skin Enterprises Inc.

The Nu Skin Enterprises Inc. (NYSE: NUS) family of companies includes Nu Skin and Rhyz Inc. Nu Skin is an intelligent beauty and wellness company, powered by a dynamic affiliate opportunity platform, which operates in nearly 50 markets worldwide. Backed by more than 40 years of scientific research, the company’s products help people look, feel and live their best with brands including Nu Skin® personal care, Pharmanex® nutrition and ageLOC® anti-aging, which includes an award-winning line of beauty and wellness device systems. Formed in 2018, Rhyz is a synergistic ecosystem of consumer, technology and manufacturing companies focused on innovation within the beauty, wellness and lifestyle categories.

*Source Euromonitor International Limited: At-Home Beauty and Wellness Device Systems on a total retail level in RSP, excluding salon services that may offer packages; research conducted May - July 2025.

View source version on businesswire.com: https://www.businesswire.com/news/home/20251218920941/en/

Media: media@nuskin.com, (801) 345-6397

Investors: investorrelations@nuskin.com, (801) 345-3577

Source: Nu Skin Enterprises Inc.